Lung cancer is one of the common malignant cancers worldwide. Immune checkpoint
inhibitor (ICI) therapy has improved survival of lung cancer patients. However, ICI therapy …

Simple Summary As a solid tumor, melanoma is not only a tumor mass of monolithic tumor
cells, but it also contains supporting stroma, extracellular matrix (ECM), and soluble …

During the coronavirus disease 2019 (COVID-19) pandemic, which has witnessed over 772
million confirmed cases and over 6 million deaths globally, the outbreak of COVID-19 has …

Background Immune checkpoint inhibitors (ICIs) has emerged as a popular cancer treatment
approach. However, non-specific activation of T cells by ICIs can lead to immune-related …

Objective: This study evaluated the efficacy and safety of the gemcitabine and oxaliplatin
intrathoracic perfusion chemotherapy (IPCGOR) regimen combined with interleukin-2 (IL-2) …

Introduction Colorectal cancer (CRC) presents a substantial challenge characterized by
unacceptably high mortality and morbidity, primarily attributed to delayed diagnosis and …

Cancer immunotherapy has rapidly transformed cancer treatment, yet resistance remains a
significant hurdle, limiting its efficacy in many patients. Circular RNAs (circRNAs), a novel …

Background The interaction between pyroptosis—a form of programmed cell death—and
tumor immunity represents a burgeoning field of interest. Pyroptosis exhibits a dual role in …

The emergence of immune checkpoint inhibitors (ICIs) has led to a dramatic paradigm shift
within the landscape of cancer treatment, igniting significant interest in their potential …

In recent years, the immunotherapy of gastric cancer has made a breakthrough. With the
emergence of immune checkpoint inhibitors, blocking the inhibitory molecules in the body …